Manulife Financial Corpor... (MFC)
NYSE: MFC
· Real-Time Price · USD
30.39
-0.20 (-0.65%)
At close: Aug 15, 2025, 3:59 PM
30.40
0.01%
After-hours: Aug 15, 2025, 06:10 PM EDT
Manulife Financial Income Statement
Financials in CAD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 37.44B | 45.58B | 48.52B | 43.17B | 42.38B | 42.31B | 48.48B | 46.57B | 31.83B | 15.28B | 21.53B | 29.71B | 57.85B | 59.84B | 56.12B | 53.57B | 55.38B |
Cost of Revenue | 11.85B | 15.45B | 13.22B | 2.94B | 3.26B | 1.75B | 2.48B | 2.48B | 2.48B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 25.59B | 30.13B | 35.29B | 40.22B | 39.13B | 40.56B | 46B | 44.09B | 29.36B | 15.28B | 21.53B | 29.71B | 57.85B | 59.84B | 56.12B | 53.57B | 55.38B |
Operating Income | 6.54B | 7.09B | 7.1B | 6.71B | 7.54B | 6.9B | 8.06B | 8.24B | 10.02B | 13.34B | 12.6B | 11.96B | 11.21B | 8.55B | 8.29B | 9.13B | 6.86B |
Interest Income | 17.77B | 17.48B | 17.05B | 16.85B | 16.63B | 16.12B | 16.04B | 15.92B | 15.78B | 15.96B | 15.91B | 15.79B | 15.9B | 15.7B | 15.31B | 14.89B | 14.43B |
Pretax Income | 6.54B | 7.09B | 7.1B | 5.93B | 5.99B | 6.45B | 6.47B | 5.78B | 1.69B | -1.69B | -1.35B | -358M | 5.59B | 8.13B | 7.71B | 8.4B | 5.94B |
Net Income | 5.27B | 5.63B | 5.71B | 4.97B | 5.02B | 5.46B | 5.67B | 5.79B | 2.49B | -88M | -38M | -95M | 4.66B | 6.66B | 6.42B | 6.83B | 4.95B |
Selling & General & Admin | 4.96B | 4.86B | 4.71B | 4.55B | 4.35B | 4.33B | 5.29B | 5.16B | 5.03B | 4.87B | 4.73B | 5.72B | 6.73B | 7.83B | 7.8B | 7.75B | 7.7B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 13B | 21.07B | 25.64B | 33.66B | 34.47B | 35.66B | 42.99B | 43.4B | 35.13B | 29.05B | 35.44B | 40.63B | 61.43B | 52.01B | 48.33B | 45.83B | 47.68B |
Operating Expenses | 20.13B | 28.09B | 32.52B | 39.59B | 38.81B | 39.99B | 48.28B | 48.56B | 41.11B | 34.88B | 41.12B | 47.31B | 68.16B | 59.84B | 56.12B | 53.57B | 55.38B |
Interest Expense | 1.64B | 1.68B | 1.65B | 1.66B | 1.61B | 1.55B | 1.58B | 1.54B | 1.47B | 1.35B | 1.17B | 1.06B | 1B | 1.01B | 1.04B | 1.05B | 1.06B |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -986M | -986M | -986M | -986M | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 30.91B | 38.49B | 41.41B | 38.21B | 38.81B | 39.99B | 48.28B | 48.56B | 41.14B | 34.91B | 41.15B | 47.34B | 68.16B | 59.84B | 56.12B | 53.57B | 54.55B |
Income Tax Expense | 1.01B | 1.21B | 1.13B | 803M | 816M | 845M | 689M | 800M | -18M | -767M | -503M | -397M | 766M | 1.21B | 1.01B | 1.22B | 605M |
Shares Outstanding (Basic) | 1.72B | 1.77B | 1.77B | 1.79B | 1.8B | 1.88B | 1.88B | 1.88B | 1.88B | 1.88B | 1.9B | 1.92B | 1.94B | 1.94B | 1.94B | 1.94B | 1.94B |
Shares Outstanding (Diluted) | 1.73B | 1.78B | 1.78B | 1.8B | 1.81B | 1.88B | 1.88B | 1.88B | 1.88B | 1.88B | 1.9B | 1.92B | 1.94B | 1.95B | 1.95B | 1.95B | 1.95B |
EPS (Basic) | 2.66 | 2.86 | 2.85 | 2.37 | 2.34 | 2.62 | 2.71 | 2.41 | 0.78 | -0.61 | -0.52 | 0.05 | 2.51 | 3.55 | 3.41 | 3.65 | 2.67 |
EPS (Diluted) | 2.63 | 2.83 | 2.83 | 2.35 | 2.33 | 2.61 | 2.70 | 2.41 | 0.78 | -0.61 | -0.53 | 0.04 | 2.50 | 3.54 | 3.40 | 3.64 | 2.66 |
EBITDA | 6.3B | 7.26B | 7B | 6.42B | 6.99B | 7.98B | 8.61B | 9.04B | 8.8B | 10.66B | 10.82B | 10.53B | 12.5B | 9.66B | 9.3B | 10.04B | 7.62B |
EBIT | 7.79B | 8.77B | 8.75B | 7.59B | 7.6B | 8.01B | 8.05B | 8.47B | 8.23B | 10.1B | 10.26B | 9.99B | 11.97B | 9.14B | 8.74B | 9.45B | 7B |
Depreciation & Amortization | -914M | -340M | 16M | 604M | 589M | 581M | 558M | 552M | 543M | 538M | 530M | 526M | 530M | 529M | 556M | 589M | 614M |